ALKERMES reported $138.7M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Amgen AMGN:US $ 4152M 37M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Bluebird Bio BLUE:US $ 0.77M 12.74M
Bristol Myers Squibb BMY:US $ 2163M 26M
Coherus Biosciences CHRS:US $ 37.58M 58.5M
Eli Lilly And LLY:US $ 3907.4M 82.5M
Gilead Sciences GILD:US $ 2797M 191M
H. Lundbeck A/S LUN:DC 2.76B 160M
Heron Therapeutics HRTX:US $ 41.5M 1.3M
Horizon Pharma HZNP:US $ 237.43M 21.24M
Intra Cellular Therapies ITCI:US $ 8.17M 0.4M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
JAZZ PHA JAZZ:US $ 1137.85M 113.41M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Otsuka Holdings 4578:JP Y 178892M 3160M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Revance Therapeutics RVNC:US $ 10.19M 5.13M
Teva Pharmaceutical Industries TEVA:US $ 4167M 195M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M
Zogenix ZGNX:US $ 3.5M 0.58M